SteadyMed Ltd.
DelistedCIK 1619087fmd_1M81PPDTSVDAR6Q4EK0979X97NManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Jun 30, 2018, 18 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|
| Total revenues | – | 1 | 1 | 1 |
| Research and development | 13 | 20 | 21 | 15 |
| Selling, general and administrative | – | 6 | 8 | 7 |
| Total operating expenses | – | 26 | 28 | 22 |
| Operating income | (16) | (25) | (27) | (20) |
| Interest expense | – | 0 | 1 | 3 |
| Interest and investment income | – | 0 | 0 | 0 |
| Other non-operating income (expense) | (3) | 0 | 2 | (3) |
| Income before taxes | (19) | (25) | (25) | (23) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (19) | (25) | (26) | (23) |
| Net income | (19) | (25) | (26) | (23) |
| Net income to common shareholders | (22) | (26) | (26) | (23) |